Cubist Systematic Strategies’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-132,451
| Closed | -$9.89M | – | 3149 |
|
|
2025
Q2 | $9.89M | Buy |
+132,451
| New | +$10.4M | 0.05% | 604 |
|
|
2024
Q2 | – | Sell |
-4,562
| Closed | -$457K | – | 3260 |
|
|
2024
Q1 | $457K | Buy |
4,562
+4,560
| +228,000% | +$401K | ﹤0.01% | 2659 |
|
|
2023
Q4 | $180 | Sell |
2
-107,249
| -100% | -$8.55M | ﹤0.01% | 3498 |
|
|
2023
Q3 | $8.23M | Sell |
107,251
-74,280
| -41% | -$6.16M | 0.06% | 477 |
|
|
2023
Q2 | $15.2M | Buy |
181,531
+137,166
| +309% | +$11.2M | 0.1% | 229 |
|
|
2023
Q1 | $3.74M | Sell |
44,365
-64,478
| -59% | -$5.54M | 0.02% | 1161 |
|
|
2022
Q4 | $8.86M | Buy |
108,843
+19,444
| +22% | +$1.57M | 0.05% | 562 |
|
|
2022
Q3 | $6.35M | Buy |
89,399
+66,941
| +298% | +$6.02M | 0.04% | 840 |
|
|
2022
Q2 | $2.02M | Sell |
22,458
-160,301
| -88% | -$16.6M | 0.01% | 1856 |
|
|
2022
Q1 | $20.5M | Buy |
182,759
+152,179
| +498% | +$17.8M | 0.17% | 62 |
|
|
2021
Q4 | $3.7M | Sell |
30,580
-156,996
| -84% | -$17.5M | 0.04% | 859 |
|
|
2021
Q3 | $18.9M | Buy |
187,576
+154,751
| +471% | +$17.1M | 0.24% | 42 |
|
|
2021
Q2 | $3.83M | Sell |
32,825
-69,067
| -68% | -$8.29M | 0.04% | 698 |
|
|
2021
Q1 | $11.2M | Buy |
101,892
+65,524
| +180% | +$7.11M | 0.14% | 134 |
|
|
2020
Q4 | $3.65M | Buy |
36,368
+29,638
| +440% | +$2.75M | 0.05% | 600 |
|
|
2020
Q3 | $526K | Sell |
6,730
-2,947
| -30% | -$222K | 0.01% | 1716 |
|
|
2020
Q2 | $674K | Sell |
9,677
-45,749
| -83% | -$2.88M | 0.01% | 1418 |
|
|
2020
Q1 | $2.58M | Sell |
55,426
-35,354
| -39% | -$2.27M | 0.07% | 378 |
|
|
2019
Q4 | $7.2M | Sell |
90,780
-26,272
| -22% | -$2.02M | 0.13% | 177 |
|
|
2019
Q3 | $8.64M | Buy |
117,052
+21,547
| +23% | +$1.55M | 0.17% | 136 |
|
|
2019
Q2 | $7.43M | Buy |
95,505
+56,162
| +143% | +$4.27M | 0.14% | 177 |
|
|
2019
Q1 | $2.98M | Buy |
39,343
+19,922
| +103% | +$1.58M | 0.1% | 289 |
|
|
2018
Q4 | $1.42M | Buy |
19,421
+11,921
| +159% | +$950K | 0.07% | 417 |
|
|
2018
Q3 | $718K | Sell |
7,500
-23,316
| -76% | -$2.31M | 0.04% | 624 |
|
|
2018
Q2 | $3.08M | Buy |
30,816
+26,350
| +590% | +$2.78M | 0.15% | 148 |
|
|
2018
Q1 | $472K | Sell |
4,466
-665
| -13% | -$67.2K | 0.03% | 830 |
|
|
2017
Q4 | $475K | Sell |
5,131
-6,933
| -57% | -$630K | 0.03% | 936 |
|
|
2017
Q3 | $1.09M | Buy |
12,064
+4,027
| +50% | +$343K | 0.06% | 391 |
|
|
2017
Q2 | $675K | Buy |
8,037
+4,102
| +104% | +$331K | 0.04% | 607 |
|
|
2017
Q1 | $318K | Sell |
3,935
-1,269
| -24% | -$99.8K | 0.02% | 868 |
|
|
2016
Q4 | $391K | Buy |
5,204
+5,104
| +5,104% | +$369K | 0.03% | 805 |
|
|
2016
Q3 | $7K | Sell |
100
-6,824
| -99% | -$458K | ﹤0.01% | 1645 |
|
|
2016
Q2 | $470K | Sell |
6,924
-1,270
| -15% | -$93.3K | 0.03% | 811 |
|
|
2016
Q1 | $592K | Buy |
8,194
+4,525
| +123% | +$296K | 0.03% | 686 |
|
|
2015
Q4 | $248K | Sell |
3,669
-9,506
| -72% | -$665K | 0.01% | 1231 |
|
|
2015
Q3 | $853K | Buy |
13,175
+2,850
| +28% | +$210K | 0.04% | 663 |
|
|
2015
Q2 | $845K | Sell |
10,325
-8,629
| -46% | -$665K | 0.04% | 665 |
|
|
2015
Q1 | $1.31M | Sell |
18,954
-4,935
| -21% | -$356K | 0.06% | 444 |
|
|
2014
Q4 | $1.81M | Buy |
23,889
+15,924
| +200% | +$1.26M | 0.1% | 279 |
|
|
2014
Q3 | $644K | Buy |
7,965
+1,234
| +18% | +$103K | 0.04% | 681 |
|
|
2014
Q2 | $588K | Buy |
+6,731
| New | +$585K | 0.04% | 668 |
|
Other funds holding EMN
Cubist Systematic Strategies's EMN Position: Q3 2025 in Review
Cubist Systematic Strategies sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 132,451 shares — an estimated $9.89M sold.
Cubist Systematic Strategies first reported a position in EMN in Q2 2014 and held it in 41 quarters. The position peaked at $20.5M in Q1 2022. 662 funds tracked by Wall St. Rank hold EMN as of Q3 2025.
- Cubist Systematic Strategies reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
- Cubist Systematic Strategies sold 132,451 Eastman Chemical shares in Q3 2025, an estimated $9.89M.
- Cubist Systematic Strategies first reported a position in Eastman Chemical in Q2 2014 and held it in 41 quarters.
- Cubist Systematic Strategies's Eastman Chemical position peaked at $20.5M in Q1 2022.
- 662 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.